20 Jul iCell Gene Therapeutics
Posted at 20:33h
in
Jennifer Chow, CEO
Oct. 6 | 4:30pm | FLW Ballroom G
Stony Brook, NY
(Private)
iCell Gene Therapeutics is a private, clinical-stage biopharmaceutical company with a robust pipeline of autologous and in vivo CAR T cell therapies for autoimmune diseases and cancer. In addition to our lead asset, ICG318, iCell Gene has a robust pipeline of in vivo and autologous CAR T cell therapies for autoimmune diseases, solid tumors and hematological malignancies.